Literature DB >> 7790113

Cytogenetic findings in malignant peripheral nerve sheath tumors.

F Mertens1, A Rydholm, H F Bauer, J Limon, B Nedoszytko, A Szadowska, H Willén, S Heim, F Mitelman, N Mandahl.   

Abstract

Clonal chromosome aberrations were detected in 8 short-term cultured malignant peripheral nerve sheath tumors (MPNST). Seven had a near-triploid chromosome number and I was in the hyperhaploid-hypodiploid range. No recurrent structural rearrangements were found; the bands most frequently involved (3 tumors) were 7p11, 12p13 and 14q11. The most common numerical changes were loss of a sex chromosome (all tumors) and loss of at least 1 copy of chromosomes 8, 16 and 22 (4 tumors). Pooling our data with those on the 20 previously published MPNST with abnormal karyotypes, we found that the chromosome number has often been in the triploid range (12 tumors), with stem line variation between 34 and 270. All chromosome arms, except 22p and the Y chromosome, were involved in recombinations. The most frequently rearranged bands were 7p22 (6 tumors) and 1p21, 7p11 and 14q11 (5 tumors each). Most numerical and unbalanced structural aberrations have led to loss of genetic material, in particular from Xq26-qter (13 tumors); 11q22-qter and 13p (12 tumors); 9p22-pter, 11p13-pter, 17p and 17q11-21 (11 tumors); 1p22-32 and 1p34-pter (10 tumors) and 6q25-qter and chromosome 16 (9 tumors).

Entities:  

Mesh:

Year:  1995        PMID: 7790113     DOI: 10.1002/ijc.2910610609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

Authors:  G P Nielsen; A O Stemmer-Rachamimov; Y Ino; M B Moller; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model.

Authors:  Karlyne M Reilly; Karl W Broman; Roderick T Bronson; Shirley Tsang; Dagan A Loisel; Emily S Christy; Zhonghe Sun; John Diehl; David J Munroe; Robert G Tuskan
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.

Authors:  C D Fletcher; P Dal Cin; I de Wever; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van den Berghe; R Vanni; H Willén
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 4.  Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours.

Authors:  J F Graadt van Roggen; J V Bovée; J Morreau; P C Hogendoorn
Journal:  J Clin Pathol       Date:  1999-07       Impact factor: 3.411

5.  Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.

Authors:  Syed J Kazmi; Stephanie J Byer; Jenell M Eckert; Amy N Turk; Richard P H Huijbregts; Nicole M Brossier; William E Grizzle; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Am J Pathol       Date:  2013-01-13       Impact factor: 4.307

6.  Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors.

Authors:  Helge R Brekke; Matthias Kolberg; Rolf I Skotheim; Kirsten S Hall; Bodil Bjerkehagen; Björn Risberg; Henryk A Domanski; Nils Mandahl; Knut Liestøl; Sigbjørn Smeland; Håvard E Danielsen; Fredrik Mertens; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2009-01-30       Impact factor: 12.300

Review 7.  The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.

Authors:  Steven L Carroll
Journal:  Am J Pathol       Date:  2015-12-28       Impact factor: 4.307

8.  Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.

Authors:  Eric P Rahrmann; Branden S Moriarity; George M Otto; Adrienne L Watson; Kwangmin Choi; Margaret H Collins; Margaret Wallace; Beau R Webber; Colleen L Forster; Anthony E Rizzardi; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Am J Pathol       Date:  2014-05-13       Impact factor: 4.307

Review 9.  How does the Schwann cell lineage form tumors in NF1?

Authors:  Steven L Carroll; Nancy Ratner
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

10.  Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.

Authors:  Eric P Rahrmann; Adrienne L Watson; Vincent W Keng; Kwangmin Choi; Branden S Moriarity; Dominic A Beckmann; Natalie K Wolf; Aaron Sarver; Margaret H Collins; Christopher L Moertel; Margaret R Wallace; Bernat Gel; Eduard Serra; Nancy Ratner; David A Largaespada
Journal:  Nat Genet       Date:  2013-05-19       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.